Efgartigimod Alfa for generalized Myasthenia Gravis
Author: Dr. Ahmed Farhan
Published: 2 years ago0 Replies
Efgartigimod Alfa is a monoclonal antibody that is used in the treatment of generalized myasthenia gravis. It binds to the Fc receptors of human IgG-1 in patients who are Ach-R (acetylcholine receptor) antibody receptor positive.